Sernova Retains FronTier Merchant Capital for North America Investor Relations and Marketing

Sernova Corp, a leading clinical stage regenerative medicine company, announced that FronTier Merchant Capital Group will provide North American investor relations (IR) and strategic marketing for Sernova with a goal of increasing market awareness through financial market communications.

Read the full press release here.